Guggenheim Reiterates Buy Rating on Twist Bioscience (TWST)

August 24, 2026 6:43 AM

Guggenheim analyst Subbu Nambi reiterated a Buy rating and $107.00 price target on Twist Bioscience (NASDAQ: TWST).The analyst commented: "We ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found